Adjuvant treatment directed by the 50-gene Prosigna assay was noninferior to standard chemotherapy f...
IBCFS With Prosigna-Guided Adjuvant Therapy Is Noninferior to Chemoendocrine Therapy in ER+/HER2– Early Breast Cancer
Adjuvant treatment directed by the 50-gene Prosigna assay was noninferior to standard chemotherapy followed by endocrine therapy for invasive breast...
Author: OncLive
Read Original Article